X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The prospective, single-arm study followed a population of 283 patients and determined that Solesta provided clinically significant, sustained improvement in symptoms and quality of life, without the occurrence of any serious adverse events.
Lead Product(s): Hyaluronic Acid,Dextranomer
Therapeutic Area: Gastroenterology Product Name: Solesta
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 29, 2022
Details:
The non-dilutive capital provides financial support for commercial and product development including Barrigel, is made from NASHA. Barrigel is an injectable biodegradable material that separates prostate from rectum to protect it during radiation therapy for prostate cancer.
Lead Product(s): Hyaluronic Acid
Therapeutic Area: Oncology Product Name: Barrigel
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Silicon Valley Bank
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Financing October 28, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
